Literature DB >> 25582655

Unrecognised myocardial infarction in patients with schizophrenia.

Jimmi Nielsen1, Jacob Juel1, Karam Sadoon Alzuhairi, Karam Sadoon Majeed Al Zuhairi1, Rasmus Friis1, Claus Graff2, Jørgen Kim Kanters3, Svend Eggert Jensen4.   

Abstract

OBJECTIVE: Schizophrenia is associated with a reduction of the lifespan by 20 years, with type II diabetes and cardiovascular disease contributing the most to the increased mortality. Unrecognised or silent myocardial infarction (MI) occurs in ~30% of the population, but the rates of unrecognised MI in patients with schizophrenia have only been sparsely investigated.
METHOD: Electrocardiograms (ECG) from three psychiatric hospitals in Denmark were manually interpreted for signs of previous MI. Subsequently, ECGs were linked to the National Patient Registry in order to determine whether patients had a diagnosis consistent with previous MI.
RESULTS: A total of 937 ECGs were interpreted, 538 men (57.4%) and 399 women (42.6%). Mean age at the time of ECG acquisition was 40.6 years (95% CI: 39.7-41.5, range: 15.9-94.6). We identified 32 patients with positive ECG signs of MIs. Only two of these patients had a diagnosis of MI in the National Patient Registry. An additional number of eight patients had a diagnosis of MI in the Danish National Patient Registry, but with no ECG signs of previous MI. This means that 30 out of 40 (75%) MIs were unrecognised. Only increasing age was associated with unrecognised MI in a stepwise multiple logistic regression model compared with patients with no history of MI, OR: 1.03 per year of age, 95% CI: 1.00-1.06, p=0.021.
CONCLUSION: Unrecognised MI is common among patients with schizophrenia and may contribute to the increased mortality found in this patient group.

Entities:  

Keywords:  psychosis

Mesh:

Year:  2015        PMID: 25582655     DOI: 10.1017/neu.2014.41

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  12 in total

1.  Mortality and Revascularization among Myocardial Infarction Patients with Schizophrenia: A Population-Based Cohort Study.

Authors:  Tanya S Hauck; Ning Liu; Harindra C Wijeysundera; Paul Kurdyak
Journal:  Can J Psychiatry       Date:  2020-02-04       Impact factor: 4.356

2.  Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.

Authors:  Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

3.  Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.

Authors:  Christoffer Polcwiartek; Kristian Kragholm; Christopher Rohde; Nasseh Hashemi; Torkel Vang; Jimmi Nielsen
Journal:  Diabetologia       Date:  2017-06-07       Impact factor: 10.122

4.  Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia.

Authors:  Christoffer Polcwiartek; Kristian Kragholm; Steen M Hansen; Brett D Atwater; Daniel J Friedman; Carlo A Barcella; Claus Graff; Jonas B Nielsen; Adrian Pietersen; Jimmi Nielsen; Peter Søgaard; Christian Torp-Pedersen; Svend E Jensen
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

Review 5.  Interaction Between Race, Ethnicity, Severe Mental Illness, and Cardiovascular Disease.

Authors:  Kevin O'Gallagher; James Th Teo; Ajay M Shah; Fiona Gaughran
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

Review 6.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

7.  Treatment following myocardial infarction in patients with schizophrenia.

Authors:  Rubina Attar; Martin Berg Johansen; Jan Brink Valentin; Jørgen Aagaard; Svend Eggert Jensen
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

8.  Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness.

Authors:  I H Heiberg; R Nesvåg; L Balteskard; J G Bramness; C M Hultman; Ø Naess; T Reichborn-Kjennerud; E Ystrom; B K Jacobsen; A Høye
Journal:  Acta Psychiatr Scand       Date:  2020-02-29       Impact factor: 6.392

9.  Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness.

Authors:  I H Heiberg; B K Jacobsen; L Balteskard; J G Bramness; Ø Naess; E Ystrom; T Reichborn-Kjennerud; C M Hultman; R Nesvåg; A Høye
Journal:  Acta Psychiatr Scand       Date:  2019-03-29       Impact factor: 6.392

10.  Schizophrenia Plays a Negative Role in the Pathological Development of Myocardial Infarction at Multiple Biological Levels.

Authors:  Xiaorong Yang; Yao Chen; Huiyao Wang; Xia Fu; Kamil Can Kural; Hongbao Cao; Ying Li
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.